

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | endothelial cell chemotaxis (GO:0035767) | 5.80388312 |
| 2 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.85443879 |
| 3 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.62715648 |
| 4 | cellular extravasation (GO:0045123) | 4.49461726 |
| 5 | regulation of gamma-delta T cell activation (GO:0046643) | 4.47354596 |
| 6 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.45576215 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.07077322 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.07077322 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 4.07077322 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.07077322 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.07077322 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.07077322 |
| 13 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.79972522 |
| 14 | positive thymic T cell selection (GO:0045059) | 3.78735803 |
| 15 | response to muramyl dipeptide (GO:0032495) | 3.76443596 |
| 16 | myeloid dendritic cell differentiation (GO:0043011) | 3.73068256 |
| 17 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.72302315 |
| 18 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.71970730 |
| 19 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.68197848 |
| 20 | myeloid dendritic cell activation (GO:0001773) | 3.46973311 |
| 21 | regulation of T cell tolerance induction (GO:0002664) | 3.45745680 |
| 22 | activated T cell proliferation (GO:0050798) | 3.45227548 |
| 23 | interleukin-1-mediated signaling pathway (GO:0070498) | 3.44722080 |
| 24 | T cell migration (GO:0072678) | 3.43770319 |
| 25 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.43552630 |
| 26 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 3.41311713 |
| 27 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.41122108 |
| 28 | leukocyte aggregation (GO:0070486) | 3.39254435 |
| 29 | macrophage activation involved in immune response (GO:0002281) | 3.37846238 |
| 30 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.32210460 |
| 31 | neutrophil activation involved in immune response (GO:0002283) | 3.27995492 |
| 32 | positive T cell selection (GO:0043368) | 3.26171552 |
| 33 | regulation of chronic inflammatory response (GO:0002676) | 3.25736776 |
| 34 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.23791990 |
| 35 | regulation of vitamin metabolic process (GO:0030656) | 3.22940523 |
| 36 | microglial cell activation (GO:0001774) | 3.20805054 |
| 37 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.20497725 |
| 38 | T-helper cell differentiation (GO:0042093) | 3.20497725 |
| 39 | regulation of immunoglobulin secretion (GO:0051023) | 3.20396184 |
| 40 | cell proliferation involved in kidney development (GO:0072111) | 3.19072446 |
| 41 | regulation of interleukin-2 production (GO:0032663) | 3.17889808 |
| 42 | positive regulation of astrocyte differentiation (GO:0048711) | 3.17241811 |
| 43 | positive regulation of interleukin-2 production (GO:0032743) | 3.13968835 |
| 44 | NIK/NF-kappaB signaling (GO:0038061) | 3.12392648 |
| 45 | thymic T cell selection (GO:0045061) | 3.05571910 |
| 46 | B cell homeostasis (GO:0001782) | 3.03248574 |
| 47 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.99647294 |
| 48 | negative thymic T cell selection (GO:0045060) | 2.98736002 |
| 49 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.98230702 |
| 50 | T cell costimulation (GO:0031295) | 2.97360032 |
| 51 | negative T cell selection (GO:0043383) | 2.95341382 |
| 52 | response to protozoan (GO:0001562) | 2.94508248 |
| 53 | lymphocyte costimulation (GO:0031294) | 2.94216386 |
| 54 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.91579037 |
| 55 | positive regulation of extracellular matrix organization (GO:1903055) | 2.91212120 |
| 56 | response to peptidoglycan (GO:0032494) | 2.91050752 |
| 57 | lung lobe morphogenesis (GO:0060463) | 2.90843659 |
| 58 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.90789760 |
| 59 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.90789760 |
| 60 | positive regulation of osteoclast differentiation (GO:0045672) | 2.88375907 |
| 61 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.88074735 |
| 62 | defense response to protozoan (GO:0042832) | 2.86741907 |
| 63 | regulation of monocyte differentiation (GO:0045655) | 2.86159584 |
| 64 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.84828438 |
| 65 | cellular response to interleukin-15 (GO:0071350) | 2.84804146 |
| 66 | T-helper 1 type immune response (GO:0042088) | 2.84599861 |
| 67 | oligosaccharide catabolic process (GO:0009313) | 2.83986250 |
| 68 | positive regulation of humoral immune response (GO:0002922) | 2.82511141 |
| 69 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.82103852 |
| 70 | T cell differentiation involved in immune response (GO:0002292) | 2.81798275 |
| 71 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.81798275 |
| 72 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.81798275 |
| 73 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.81303839 |
| 74 | macrophage activation (GO:0042116) | 2.80199302 |
| 75 | T cell selection (GO:0045058) | 2.80049301 |
| 76 | regulation of regulatory T cell differentiation (GO:0045589) | 2.79698062 |
| 77 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.79097333 |
| 78 | positive regulation of glomerulus development (GO:0090193) | 2.79065976 |
| 79 | cellular response to antibiotic (GO:0071236) | 2.77743581 |
| 80 | negative regulation of T cell mediated immunity (GO:0002710) | 2.76371699 |
| 81 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.76353653 |
| 82 | regulation of isotype switching (GO:0045191) | 2.75954902 |
| 83 | regulation of B cell mediated immunity (GO:0002712) | 2.75213276 |
| 84 | tolerance induction (GO:0002507) | 2.74910042 |
| 85 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.74685753 |
| 86 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.74685753 |
| 87 | myeloid cell activation involved in immune response (GO:0002275) | 2.74169995 |
| 88 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.74118729 |
| 89 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.73701205 |
| 90 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.73701205 |
| 91 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.73667178 |
| 92 | regulation of tolerance induction (GO:0002643) | 2.73269053 |
| 93 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.70660939 |
| 94 | T cell proliferation (GO:0042098) | 2.70095060 |
| 95 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.69392761 |
| 96 | alpha-beta T cell differentiation (GO:0046632) | 2.67718847 |
| 97 | positive regulation of tolerance induction (GO:0002645) | 2.67689421 |
| 98 | negative regulation of interleukin-2 production (GO:0032703) | 2.67224678 |
| 99 | interferon-gamma production (GO:0032609) | 2.66577537 |
| 100 | response to laminar fluid shear stress (GO:0034616) | 2.66479382 |
| 101 | positive regulation of interleukin-12 production (GO:0032735) | 2.65901777 |
| 102 | neutrophil activation (GO:0042119) | 2.64819833 |
| 103 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.63891644 |
| 104 | granulocyte activation (GO:0036230) | 2.62877822 |
| 105 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.61696635 |
| 106 | myeloid leukocyte activation (GO:0002274) | 2.60967039 |
| 107 | T cell lineage commitment (GO:0002360) | 2.60931839 |
| 108 | type I interferon signaling pathway (GO:0060337) | 2.60458199 |
| 109 | cellular response to type I interferon (GO:0071357) | 2.60458199 |
| 110 | monocyte chemotaxis (GO:0002548) | 2.60066912 |
| 111 | response to type I interferon (GO:0034340) | 2.59167751 |
| 112 | positive regulation of isotype switching (GO:0045830) | 2.58820736 |
| 113 | mast cell activation (GO:0045576) | 2.58795301 |
| 114 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.57254107 |
| 115 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.56844158 |
| 116 | positive regulation of B cell mediated immunity (GO:0002714) | 2.56844158 |
| 117 | immunoglobulin mediated immune response (GO:0016064) | 2.55181034 |
| 118 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.54778403 |
| 119 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.54681198 |
| 120 | dendritic cell differentiation (GO:0097028) | 2.54477821 |
| 121 | positive regulation of metanephros development (GO:0072216) | 2.54373584 |
| 122 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.53299190 |
| 123 | germinal center formation (GO:0002467) | 2.53272268 |
| 124 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.52273684 |
| 125 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.50135431 |
| 126 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.50135431 |
| 127 | regulation of podosome assembly (GO:0071801) | 2.49889392 |
| 128 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.49329028 |
| 129 | negative regulation of interleukin-12 production (GO:0032695) | 2.49180255 |
| 130 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.49107646 |
| 131 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.48028135 |
| 132 | positive regulation of type 2 immune response (GO:0002830) | 2.47622325 |
| 133 | negative regulation of cell killing (GO:0031342) | 2.47506038 |
| 134 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.47506038 |
| 135 | * cellular response to gonadotropin stimulus (GO:0071371) | 2.47300957 |
| 136 | negative regulation of lipid storage (GO:0010888) | 2.47052818 |
| 137 | positive regulation of macrophage differentiation (GO:0045651) | 2.42311255 |
| 138 | heterotypic cell-cell adhesion (GO:0034113) | 2.42281936 |
| 139 | response to interleukin-15 (GO:0070672) | 2.41705215 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.44756320 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.51312308 |
| 3 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.19043502 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.09312882 |
| 5 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.36379375 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.30201170 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.14621615 |
| 8 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.13630324 |
| 9 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.94956712 |
| 10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.91093611 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.86567050 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.77183031 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.75994573 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.61037094 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.37913134 |
| 16 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.29300851 |
| 17 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.28322973 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.26342168 |
| 19 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.20810586 |
| 20 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.16861815 |
| 21 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.12812005 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.07481558 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.03142853 |
| 24 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.97160036 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.91512313 |
| 26 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.88567245 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.83335203 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.83035002 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.80315832 |
| 30 | * MYB_26560356_Chip-Seq_TH2_Human | 1.75457456 |
| 31 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.66908720 |
| 32 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.65433699 |
| 33 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.65304406 |
| 34 | * MAF_26560356_Chip-Seq_TH2_Human | 1.63509330 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.60831809 |
| 36 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.53248414 |
| 37 | MAF_26560356_Chip-Seq_TH1_Human | 1.52729989 |
| 38 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.50143791 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.49851836 |
| 40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.48151158 |
| 41 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.47874054 |
| 42 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.47607907 |
| 43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47345819 |
| 44 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.45659331 |
| 45 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.42186156 |
| 46 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.39571043 |
| 47 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.38995280 |
| 48 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.36303451 |
| 49 | CJUN_26792858_Chip-Seq_BT549_Human | 1.34636158 |
| 50 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.34159922 |
| 51 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.33127178 |
| 52 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33029889 |
| 53 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32132821 |
| 54 | * MYB_26560356_Chip-Seq_TH1_Human | 1.30609355 |
| 55 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.30297752 |
| 56 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.24842127 |
| 57 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24635241 |
| 58 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.23167521 |
| 59 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20332567 |
| 60 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.20315174 |
| 61 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.20315174 |
| 62 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.18831380 |
| 63 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.17670732 |
| 64 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17272343 |
| 65 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15845967 |
| 66 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.15429288 |
| 67 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15238009 |
| 68 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14906480 |
| 69 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.13639906 |
| 70 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.12271377 |
| 71 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.11973015 |
| 72 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.10168719 |
| 73 | UTX_26944678_Chip-Seq_JUKART_Human | 1.10148589 |
| 74 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.09843171 |
| 75 | TP53_16413492_ChIP-PET_HCT116_Human | 1.09198440 |
| 76 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.08305262 |
| 77 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.06964783 |
| 78 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06578266 |
| 79 | * WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.06255600 |
| 80 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04839439 |
| 81 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.04305112 |
| 82 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.03756941 |
| 83 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02358457 |
| 84 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01386877 |
| 85 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00685703 |
| 86 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00678996 |
| 87 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.99796726 |
| 88 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97921148 |
| 89 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.95533208 |
| 90 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94440519 |
| 91 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.94372661 |
| 92 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.94365052 |
| 93 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.92933650 |
| 94 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.91811034 |
| 95 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91407959 |
| 96 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.91096545 |
| 97 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.90558731 |
| 98 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90301172 |
| 99 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90059935 |
| 100 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89496008 |
| 101 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.88609445 |
| 102 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.88285310 |
| 103 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.88152027 |
| 104 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87660023 |
| 105 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.87443700 |
| 106 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.87133471 |
| 107 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86694657 |
| 108 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.86645488 |
| 109 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.86186171 |
| 110 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86140589 |
| 111 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.85760773 |
| 112 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85367811 |
| 113 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85367811 |
| 114 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.84645070 |
| 115 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.83520328 |
| 116 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.83304944 |
| 117 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83225911 |
| 118 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82324795 |
| 119 | MYC_22102868_ChIP-Seq_BL_Human | 0.82277907 |
| 120 | SPI1_23127762_ChIP-Seq_K562_Human | 0.82216822 |
| 121 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81658176 |
| 122 | RXR_22108803_ChIP-Seq_LS180_Human | 0.81602295 |
| 123 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81233565 |
| 124 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.80970490 |
| 125 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.80946661 |
| 126 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.80915138 |
| 127 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80311335 |
| 128 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.78837204 |
| 129 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75960603 |
| 130 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.75825435 |
| 131 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74087586 |
| 132 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.73485182 |
| 133 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.73485182 |
| 134 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.73485182 |
| 135 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.73073592 |
| 136 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.72975691 |
| 137 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.72920977 |
| 138 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.72271224 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.42580666 |
| 2 | MP0003436_decreased_susceptibility_to | 3.40989504 |
| 3 | MP0004510_myositis | 3.34339488 |
| 4 | MP0003303_peritoneal_inflammation | 3.21897220 |
| 5 | MP0003724_increased_susceptibility_to | 3.06429295 |
| 6 | MP0005000_abnormal_immune_tolerance | 2.83869354 |
| 7 | MP0009840_abnormal_foam_cell | 2.78396623 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 2.74322503 |
| 9 | MP0006082_CNS_inflammation | 2.70591908 |
| 10 | MP0001790_abnormal_immune_system | 2.66844257 |
| 11 | MP0005387_immune_system_phenotype | 2.66844257 |
| 12 | MP0003763_abnormal_thymus_physiology | 2.65805730 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.63546108 |
| 14 | MP0002419_abnormal_innate_immunity | 2.55703269 |
| 15 | MP0002405_respiratory_system_inflammati | 2.48904587 |
| 16 | MP0004947_skin_inflammation | 2.47849889 |
| 17 | MP0000685_abnormal_immune_system | 2.47203954 |
| 18 | MP0001853_heart_inflammation | 2.41661502 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.40115752 |
| 20 | MP0002254_reproductive_system_inflammat | 2.38657161 |
| 21 | MP0001851_eye_inflammation | 2.36945750 |
| 22 | MP0003300_gastrointestinal_ulcer | 2.35126538 |
| 23 | MP0001800_abnormal_humoral_immune | 2.30589959 |
| 24 | MP0002723_abnormal_immune_serum | 2.28747516 |
| 25 | MP0005671_abnormal_response_to | 2.22972094 |
| 26 | MP0002009_preneoplasia | 2.09829069 |
| 27 | MP0009785_altered_susceptibility_to | 2.07563460 |
| 28 | MP0002420_abnormal_adaptive_immunity | 2.04594354 |
| 29 | MP0001819_abnormal_immune_cell | 2.02202487 |
| 30 | MP0005025_abnormal_response_to | 2.01688459 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.97767991 |
| 32 | MP0002166_altered_tumor_susceptibility | 1.97764765 |
| 33 | MP0004381_abnormal_hair_follicle | 1.93308727 |
| 34 | MP0002998_abnormal_bone_remodeling | 1.91705504 |
| 35 | MP0002006_tumorigenesis | 1.88046333 |
| 36 | MP0002933_joint_inflammation | 1.75642894 |
| 37 | MP0003690_abnormal_glial_cell | 1.65673162 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.64012797 |
| 39 | MP0003453_abnormal_keratinocyte_physiol | 1.62837712 |
| 40 | MP0004883_abnormal_blood_vessel | 1.57559146 |
| 41 | MP0003828_pulmonary_edema | 1.52603098 |
| 42 | MP0009278_abnormal_bone_marrow | 1.52490628 |
| 43 | MP0008438_abnormal_cutaneous_collagen | 1.52259262 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.49145954 |
| 45 | MP0003448_altered_tumor_morphology | 1.48536417 |
| 46 | MP0000716_abnormal_immune_system | 1.43404678 |
| 47 | MP0003075_altered_response_to | 1.40990937 |
| 48 | MP0005390_skeleton_phenotype | 1.40742071 |
| 49 | MP0004808_abnormal_hematopoietic_stem | 1.36663684 |
| 50 | MP0002398_abnormal_bone_marrow | 1.34788987 |
| 51 | MP0002060_abnormal_skin_morphology | 1.34317296 |
| 52 | MP0005423_abnormal_somatic_nervous | 1.33915141 |
| 53 | MP0005275_abnormal_skin_tensile | 1.33392999 |
| 54 | MP0005164_abnormal_response_to | 1.33218432 |
| 55 | MP0005076_abnormal_cell_differentiation | 1.31654334 |
| 56 | MP0002139_abnormal_hepatobiliary_system | 1.31155064 |
| 57 | MP0005464_abnormal_platelet_physiology | 1.27501009 |
| 58 | MP0005023_abnormal_wound_healing | 1.24501869 |
| 59 | MP0005166_decreased_susceptibility_to | 1.23317279 |
| 60 | MP0009333_abnormal_splenocyte_physiolog | 1.20350492 |
| 61 | MP0001873_stomach_inflammation | 1.20126528 |
| 62 | MP0005310_abnormal_salivary_gland | 1.19794417 |
| 63 | MP0003866_abnormal_defecation | 1.18122388 |
| 64 | MP0005451_abnormal_body_composition | 1.17440836 |
| 65 | MP0001243_abnormal_dermal_layer | 1.15464368 |
| 66 | MP0000689_abnormal_spleen_morphology | 1.15382052 |
| 67 | MP0008004_abnormal_stomach_pH | 1.12637073 |
| 68 | MP0001727_abnormal_embryo_implantation | 1.12136611 |
| 69 | MP0000383_abnormal_hair_follicle | 1.11504610 |
| 70 | MP0005058_abnormal_lysosome_morphology | 1.11111232 |
| 71 | MP0002722_abnormal_immune_system | 1.07367495 |
| 72 | MP0003091_abnormal_cell_migration | 1.05788558 |
| 73 | * MP0003795_abnormal_bone_structure | 1.05211443 |
| 74 | MP0001216_abnormal_epidermal_layer | 1.04603325 |
| 75 | MP0000703_abnormal_thymus_morphology | 1.04564167 |
| 76 | MP0000465_gastrointestinal_hemorrhage | 1.03817345 |
| 77 | MP0003045_fibrosis | 1.03767631 |
| 78 | MP0002429_abnormal_blood_cell | 1.03010694 |
| 79 | MP0003566_abnormal_cell_adhesion | 1.01653659 |
| 80 | MP0000604_amyloidosis | 0.91196002 |
| 81 | MP0002277_abnormal_respiratory_mucosa | 0.90921434 |
| 82 | MP0008961_abnormal_basal_metabolism | 0.90397469 |
| 83 | MP0008469_abnormal_protein_level | 0.89825003 |
| 84 | MP0000858_altered_metastatic_potential | 0.86366365 |
| 85 | * MP0000920_abnormal_myelination | 0.86076482 |
| 86 | MP0002396_abnormal_hematopoietic_system | 0.85477803 |
| 87 | MP0010307_abnormal_tumor_latency | 0.85408381 |
| 88 | * MP0004742_abnormal_vestibular_system | 0.84974075 |
| 89 | MP0009764_decreased_sensitivity_to | 0.84680854 |
| 90 | MP0003172_abnormal_lysosome_physiology | 0.84306740 |
| 91 | MP0000343_altered_response_to | 0.83943230 |
| 92 | MP0005397_hematopoietic_system_phenotyp | 0.83936795 |
| 93 | MP0001545_abnormal_hematopoietic_system | 0.83936795 |
| 94 | MP0003279_aneurysm | 0.83734188 |
| 95 | MP0005257_abnormal_intraocular_pressure | 0.83334394 |
| 96 | MP0000249_abnormal_blood_vessel | 0.80147808 |
| 97 | MP0005508_abnormal_skeleton_morphology | 0.78047374 |
| 98 | MP0005647_abnormal_sex_gland | 0.77676658 |
| 99 | MP0001346_abnormal_lacrimal_gland | 0.76964654 |
| 100 | MP0005167_abnormal_blood-brain_barrier | 0.76598543 |
| 101 | MP0003191_abnormal_cellular_cholesterol | 0.75470001 |
| 102 | MP0001501_abnormal_sleep_pattern | 0.75083584 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 0.74081939 |
| 104 | MP0001191_abnormal_skin_condition | 0.72866522 |
| 105 | MP0010678_abnormal_skin_adnexa | 0.71858383 |
| 106 | MP0003329_amyloid_beta_deposits | 0.71203647 |
| 107 | MP0002090_abnormal_vision | 0.71124220 |
| 108 | MP0000371_diluted_coat_color | 0.69798850 |
| 109 | MP0009115_abnormal_fat_cell | 0.69221720 |
| 110 | MP0001663_abnormal_digestive_system | 0.68878357 |
| 111 | MP0002693_abnormal_pancreas_physiology | 0.66856279 |
| 112 | MP0009765_abnormal_xenobiotic_induced | 0.65297334 |
| 113 | MP0005171_absent_coat_pigmentation | 0.64562906 |
| 114 | MP0000733_abnormal_muscle_development | 0.63872054 |
| 115 | MP0002098_abnormal_vibrissa_morphology | 0.62513429 |
| 116 | MP0000767_abnormal_smooth_muscle | 0.62371878 |
| 117 | MP0009763_increased_sensitivity_to | 0.61500107 |
| 118 | MP0000609_abnormal_liver_physiology | 0.61343350 |
| 119 | MP0001348_abnormal_lacrimal_gland | 0.60614466 |
| 120 | MP0008057_abnormal_DNA_replication | 0.58016712 |
| 121 | MP0008260_abnormal_autophagy | 0.56671411 |
| 122 | MP0008995_early_reproductive_senescence | 0.54061523 |
| 123 | MP0002877_abnormal_melanocyte_morpholog | 0.51662884 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.60306737 |
| 2 | Stomatitis (HP:0010280) | 5.80754162 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.52722016 |
| 4 | Prostate neoplasm (HP:0100787) | 4.05261524 |
| 5 | Mediastinal lymphadenopathy (HP:0100721) | 4.04957336 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.90186055 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 3.89603941 |
| 8 | Gastrointestinal stroma tumor (HP:0100723) | 3.59029668 |
| 9 | Recurrent fungal infections (HP:0002841) | 3.58787130 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.46721464 |
| 11 | Recurrent sinusitis (HP:0011108) | 3.33018017 |
| 12 | Stomach cancer (HP:0012126) | 3.31424488 |
| 13 | Gingivitis (HP:0000230) | 3.30546466 |
| 14 | Thick nail (HP:0001805) | 3.08033263 |
| 15 | Abnormality of macrophages (HP:0004311) | 3.06785790 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.04541406 |
| 17 | Loss of speech (HP:0002371) | 2.95804507 |
| 18 | Restrictive lung disease (HP:0002091) | 2.95345418 |
| 19 | Myocardial infarction (HP:0001658) | 2.92729285 |
| 20 | Pustule (HP:0200039) | 2.91629123 |
| 21 | Increased IgM level (HP:0003496) | 2.88887865 |
| 22 | Recurrent bronchitis (HP:0002837) | 2.85510560 |
| 23 | Obstructive lung disease (HP:0006536) | 2.84016222 |
| 24 | Chronic obstructive pulmonary disease (HP:0006510) | 2.84016222 |
| 25 | Recurrent skin infections (HP:0001581) | 2.82565878 |
| 26 | Axonal loss (HP:0003447) | 2.79031341 |
| 27 | IgG deficiency (HP:0004315) | 2.77446857 |
| 28 | * Segmental peripheral demyelination/remyelination (HP:0003481) | 2.74621558 |
| 29 | Recurrent cutaneous fungal infections (HP:0011370) | 2.70052846 |
| 30 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.70052846 |
| 31 | Lymphopenia (HP:0001888) | 2.69950757 |
| 32 | Osteolytic defects of the hand bones (HP:0009699) | 2.69948350 |
| 33 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.69948350 |
| 34 | Parakeratosis (HP:0001036) | 2.62905364 |
| 35 | Vacuolated lymphocytes (HP:0001922) | 2.60453092 |
| 36 | Orchitis (HP:0100796) | 2.59830713 |
| 37 | Persistence of primary teeth (HP:0006335) | 2.59811216 |
| 38 | Mutism (HP:0002300) | 2.58291058 |
| 39 | Retrobulbar optic neuritis (HP:0100654) | 2.57419426 |
| 40 | Optic neuritis (HP:0100653) | 2.57419426 |
| 41 | Myositis (HP:0100614) | 2.54590258 |
| 42 | Neuronal loss in central nervous system (HP:0002529) | 2.50369581 |
| 43 | Abnormality of T cell number (HP:0011839) | 2.49103742 |
| 44 | Panhypogammaglobulinemia (HP:0003139) | 2.48017810 |
| 45 | Systemic lupus erythematosus (HP:0002725) | 2.46774183 |
| 46 | T lymphocytopenia (HP:0005403) | 2.46687682 |
| 47 | Abnormality of the nasal septum (HP:0000419) | 2.46376721 |
| 48 | Vasculitis (HP:0002633) | 2.46095737 |
| 49 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.45160541 |
| 50 | Increased IgE level (HP:0003212) | 2.44774869 |
| 51 | Autoimmune hemolytic anemia (HP:0001890) | 2.43703200 |
| 52 | Cheilitis (HP:0100825) | 2.38931114 |
| 53 | Chronic diarrhea (HP:0002028) | 2.38257012 |
| 54 | Increased cerebral lipofuscin (HP:0011813) | 2.37153006 |
| 55 | Arterial tortuosity (HP:0005116) | 2.33759738 |
| 56 | Alveolar cell carcinoma (HP:0006519) | 2.31314111 |
| 57 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.31221652 |
| 58 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.31221652 |
| 59 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.31221652 |
| 60 | Abnormality of the prostate (HP:0008775) | 2.31046635 |
| 61 | Leukocytosis (HP:0001974) | 2.30143861 |
| 62 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.28567123 |
| 63 | Disinhibition (HP:0000734) | 2.25380584 |
| 64 | Abnormality of T cell physiology (HP:0011840) | 2.25163929 |
| 65 | Lip pit (HP:0100267) | 2.25130826 |
| 66 | Cellulitis (HP:0100658) | 2.23640470 |
| 67 | Pulmonary infiltrates (HP:0002113) | 2.23491042 |
| 68 | Submucous cleft hard palate (HP:0000176) | 2.23083574 |
| 69 | Vascular tortuosity (HP:0004948) | 2.22142769 |
| 70 | Apathy (HP:0000741) | 2.20447511 |
| 71 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.20412559 |
| 72 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.20412559 |
| 73 | Abnormality of glycolipid metabolism (HP:0010969) | 2.20412559 |
| 74 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.18620314 |
| 75 | Periodontitis (HP:0000704) | 2.17983078 |
| 76 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.17672712 |
| 77 | Interstitial pulmonary disease (HP:0006530) | 2.13838731 |
| 78 | Joint swelling (HP:0001386) | 2.12242208 |
| 79 | Diminished motivation (HP:0000745) | 2.11081656 |
| 80 | Chronic otitis media (HP:0000389) | 2.10186505 |
| 81 | Alopecia of scalp (HP:0002293) | 2.09804022 |
| 82 | Recurrent viral infections (HP:0004429) | 2.09317462 |
| 83 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.08752535 |
| 84 | Mucopolysacchariduria (HP:0008155) | 2.08752535 |
| 85 | Cerebral aneurysm (HP:0004944) | 2.06124298 |
| 86 | Arthralgia (HP:0002829) | 2.04910810 |
| 87 | Hypergammaglobulinemia (HP:0010702) | 2.04329641 |
| 88 | Encephalitis (HP:0002383) | 2.03311359 |
| 89 | Spondylolisthesis (HP:0003302) | 2.03178061 |
| 90 | Metaphyseal irregularity (HP:0003025) | 2.03062081 |
| 91 | Keratoconjunctivitis sicca (HP:0001097) | 2.02109453 |
| 92 | Eosinophilia (HP:0001880) | 2.01756276 |
| 93 | Agammaglobulinemia (HP:0004432) | 2.01621927 |
| 94 | Flat occiput (HP:0005469) | 2.00228446 |
| 95 | Hemoptysis (HP:0002105) | 1.99214723 |
| 96 | Thin bony cortex (HP:0002753) | 1.98597229 |
| 97 | Gastrointestinal infarctions (HP:0005244) | 1.97989019 |
| 98 | Dysostosis multiplex (HP:0000943) | 1.97527270 |
| 99 | Disproportionate tall stature (HP:0001519) | 1.97467384 |
| 100 | Urethral obstruction (HP:0000796) | 1.97399197 |
| 101 | Combined immunodeficiency (HP:0005387) | 1.97266331 |
| 102 | Fatigue (HP:0012378) | 1.96937563 |
| 103 | Tetraparesis (HP:0002273) | 1.96465673 |
| 104 | Spontaneous hematomas (HP:0007420) | 1.96293308 |
| 105 | Thoracic kyphosis (HP:0002942) | 1.95967812 |
| 106 | Slow saccadic eye movements (HP:0000514) | 1.95562961 |
| 107 | Amaurosis fugax (HP:0100576) | 1.95048686 |
| 108 | Premature loss of primary teeth (HP:0006323) | 1.94747943 |
| 109 | Glomerulonephritis (HP:0000099) | 1.94143018 |
| 110 | Obstructive sleep apnea (HP:0002870) | 1.93753551 |
| 111 | Hepatosplenomegaly (HP:0001433) | 1.93532814 |
| 112 | Autoimmune thrombocytopenia (HP:0001973) | 1.93081699 |
| 113 | Severe combined immunodeficiency (HP:0004430) | 1.92425769 |
| 114 | * Ulnar claw (HP:0001178) | 1.92127109 |
| 115 | Hematochezia (HP:0002573) | 1.90287637 |
| 116 | Verrucae (HP:0200043) | 1.89099985 |
| 117 | Papilloma (HP:0012740) | 1.89099985 |
| 118 | Aortic aneurysm (HP:0004942) | 1.88444484 |
| 119 | Aortic dissection (HP:0002647) | 1.86381010 |
| 120 | Abnormality of T cells (HP:0002843) | 1.86002966 |
| 121 | Gingival bleeding (HP:0000225) | 1.85706657 |
| 122 | Aplasia cutis congenita (HP:0001057) | 1.81683180 |
| 123 | Mitral valve prolapse (HP:0001634) | 1.80272563 |
| 124 | Pulmonary artery stenosis (HP:0004415) | 1.78987110 |
| 125 | Inflammation of the large intestine (HP:0002037) | 1.78710485 |
| 126 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.77175867 |
| 127 | Premature rupture of membranes (HP:0001788) | 1.76729210 |
| 128 | Depressed nasal tip (HP:0000437) | 1.76507936 |
| 129 | IgA deficiency (HP:0002720) | 1.75287313 |
| 130 | Osteomyelitis (HP:0002754) | 1.74099334 |
| 131 | Increased density of long bones (HP:0006392) | 1.74048707 |
| 132 | Peritonitis (HP:0002586) | 1.72902017 |
| 133 | Ectropion (HP:0000656) | 1.71850112 |
| 134 | Somatic mutation (HP:0001428) | 1.71156922 |
| 135 | Recurrent pneumonia (HP:0006532) | 1.70746783 |
| 136 | Abnormality of eosinophils (HP:0001879) | 1.70426749 |
| 137 | Meningitis (HP:0001287) | 1.69670466 |
| 138 | IgM deficiency (HP:0002850) | 1.69351050 |
| 139 | Skin ulcer (HP:0200042) | 1.69241833 |
| 140 | Dilatation of the ascending aorta (HP:0005111) | 1.68478437 |
| 141 | Abnormality of male internal genitalia (HP:0000022) | 1.67845328 |
| 142 | Emphysema (HP:0002097) | 1.67126880 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.40519287 |
| 2 | MAP3K14 | 3.59343682 |
| 3 | TXK | 3.58470872 |
| 4 | PASK | 2.89170656 |
| 5 | TGFBR2 | 2.75321034 |
| 6 | IKBKB | 2.61805049 |
| 7 | EPHB1 | 2.49203412 |
| 8 | PIM2 | 2.34305454 |
| 9 | RIPK4 | 2.31058895 |
| 10 | MAPK15 | 2.22987340 |
| 11 | STK10 | 2.08140682 |
| 12 | IKBKE | 2.01772484 |
| 13 | TBK1 | 1.98523274 |
| 14 | CHUK | 1.93463574 |
| 15 | ITK | 1.89818567 |
| 16 | JAK3 | 1.89585612 |
| 17 | EPHA3 | 1.89470954 |
| 18 | MAP3K3 | 1.86340713 |
| 19 | IRAK4 | 1.80009307 |
| 20 | ZAP70 | 1.76661401 |
| 21 | TYK2 | 1.69743816 |
| 22 | NLK | 1.64703780 |
| 23 | BMPR2 | 1.62826482 |
| 24 | GRK7 | 1.61508041 |
| 25 | TAOK3 | 1.48381964 |
| 26 | FGFR4 | 1.42806140 |
| 27 | CAMKK2 | 1.36679958 |
| 28 | MST4 | 1.34948349 |
| 29 | FGFR3 | 1.31967112 |
| 30 | TRPM7 | 1.31426293 |
| 31 | RPS6KA5 | 1.31313222 |
| 32 | RPS6KA4 | 1.30999882 |
| 33 | CAMKK1 | 1.30855893 |
| 34 | BLK | 1.30783648 |
| 35 | CSK | 1.29322139 |
| 36 | PBK | 1.27323715 |
| 37 | SIK2 | 1.27223024 |
| 38 | TEC | 1.27112183 |
| 39 | HCK | 1.25430734 |
| 40 | BRD4 | 1.24194392 |
| 41 | IRAK1 | 1.17590839 |
| 42 | LCK | 1.16883928 |
| 43 | JAK1 | 1.13874581 |
| 44 | MAP2K3 | 1.10977884 |
| 45 | MAP3K11 | 1.08872480 |
| 46 | PIM1 | 1.08263433 |
| 47 | IRAK3 | 1.07770834 |
| 48 | BMPR1B | 1.04284311 |
| 49 | PDGFRB | 1.02615355 |
| 50 | CDK12 | 1.02302481 |
| 51 | DMPK | 1.02105487 |
| 52 | MAP3K10 | 1.00067979 |
| 53 | JAK2 | 0.98815803 |
| 54 | SIK1 | 0.97930603 |
| 55 | MAPK7 | 0.96528503 |
| 56 | RIPK1 | 0.95898528 |
| 57 | TYRO3 | 0.94189723 |
| 58 | DDR2 | 0.93956849 |
| 59 | STK24 | 0.93716842 |
| 60 | MAP2K2 | 0.93517322 |
| 61 | CLK1 | 0.91857808 |
| 62 | CDC42BPA | 0.89924688 |
| 63 | HIPK2 | 0.89324165 |
| 64 | MAPK12 | 0.89182538 |
| 65 | NEK9 | 0.88565951 |
| 66 | PRPF4B | 0.87458912 |
| 67 | MATK | 0.84735127 |
| 68 | MAPKAPK2 | 0.83403956 |
| 69 | SMG1 | 0.82155735 |
| 70 | MAPKAPK5 | 0.82109257 |
| 71 | TAOK1 | 0.79962387 |
| 72 | GSK3A | 0.79094634 |
| 73 | PRKCQ | 0.75087299 |
| 74 | CDK9 | 0.75032482 |
| 75 | RPS6KC1 | 0.74840571 |
| 76 | RPS6KL1 | 0.74840571 |
| 77 | SYK | 0.73478054 |
| 78 | RPS6KA1 | 0.72996221 |
| 79 | NEK6 | 0.72703246 |
| 80 | MARK3 | 0.71944770 |
| 81 | BTK | 0.69646472 |
| 82 | ERBB3 | 0.69142522 |
| 83 | MAP3K13 | 0.69081472 |
| 84 | KIT | 0.68025247 |
| 85 | MOS | 0.65236886 |
| 86 | SIK3 | 0.64178232 |
| 87 | MAP3K1 | 0.64131701 |
| 88 | BMX | 0.63985175 |
| 89 | NUAK1 | 0.63136483 |
| 90 | MAP3K5 | 0.62754230 |
| 91 | LYN | 0.62583069 |
| 92 | TNK2 | 0.61156349 |
| 93 | RPS6KA2 | 0.59140250 |
| 94 | PRKCH | 0.58402683 |
| 95 | CAMK4 | 0.57818045 |
| 96 | IRAK2 | 0.57690423 |
| 97 | MAP3K2 | 0.57412687 |
| 98 | INSR | 0.57370900 |
| 99 | CDK6 | 0.55947545 |
| 100 | MELK | 0.55586078 |
| 101 | FGR | 0.53197138 |
| 102 | TRIM28 | 0.52856718 |
| 103 | ABL1 | 0.51221555 |
| 104 | RAF1 | 0.49806212 |
| 105 | CAMK1D | 0.46995705 |
| 106 | RPS6KA6 | 0.45536720 |
| 107 | YES1 | 0.45251330 |
| 108 | EIF2AK3 | 0.45203826 |
| 109 | PDK1 | 0.45076687 |
| 110 | ERN1 | 0.44111929 |
| 111 | TAOK2 | 0.43807595 |
| 112 | EGFR | 0.42399473 |
| 113 | CSF1R | 0.40570911 |
| 114 | MARK2 | 0.40541575 |
| 115 | FES | 0.38724640 |
| 116 | CAMK1G | 0.38291840 |
| 117 | SGK2 | 0.36817507 |
| 118 | ADRBK2 | 0.36763603 |
| 119 | MAPK1 | 0.36319478 |
| 120 | MAPK3 | 0.33502766 |
| 121 | TGFBR1 | 0.33177109 |
| 122 | PAK2 | 0.31131316 |
| 123 | SGK3 | 0.30132404 |
| 124 | PDK2 | 0.27352894 |
| 125 | FYN | 0.27211900 |
| 126 | PRKCD | 0.26864188 |
| 127 | ROCK2 | 0.26816200 |
| 128 | MAPK4 | 0.26694562 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.72323079 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.68206057 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.62332940 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.50855048 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.50311549 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.37804799 |
| 7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.18706245 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.00340052 |
| 9 | Malaria_Homo sapiens_hsa05144 | 1.99946111 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.97890588 |
| 11 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.85525900 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.83873019 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.82418072 |
| 14 | Measles_Homo sapiens_hsa05162 | 1.76268930 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.74081780 |
| 16 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.73179860 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 1.72522799 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.72173469 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.69213114 |
| 20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.68942089 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.68535536 |
| 22 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.64702764 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.59069273 |
| 24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.55994199 |
| 25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.55213042 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.48715419 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.48685191 |
| 28 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.44229723 |
| 29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.42685353 |
| 30 | Salmonella infection_Homo sapiens_hsa05132 | 1.42076306 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.33020053 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.31514943 |
| 33 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.29060240 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.25979159 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.25296497 |
| 36 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.23375253 |
| 37 | * Hepatitis B_Homo sapiens_hsa05161 | 1.21584047 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.21357599 |
| 39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.20168808 |
| 40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.19218815 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.18354274 |
| 42 | Phagosome_Homo sapiens_hsa04145 | 1.13042722 |
| 43 | Lysosome_Homo sapiens_hsa04142 | 1.09731407 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 1.08933542 |
| 45 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.08849373 |
| 46 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.08144307 |
| 47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.07710195 |
| 48 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.06495699 |
| 49 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.06014534 |
| 50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05022367 |
| 51 | Prion diseases_Homo sapiens_hsa05020 | 1.04528976 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 1.00405996 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.98286359 |
| 54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.95928959 |
| 55 | Amoebiasis_Homo sapiens_hsa05146 | 0.94429849 |
| 56 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.92719368 |
| 57 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.88751820 |
| 58 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.88613499 |
| 59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.87693440 |
| 60 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.84832755 |
| 61 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80296757 |
| 62 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.78400834 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.76273850 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.75058031 |
| 65 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.71925979 |
| 66 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.69715219 |
| 67 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.68657826 |
| 68 | Circadian rhythm_Homo sapiens_hsa04710 | 0.68560274 |
| 69 | Prostate cancer_Homo sapiens_hsa05215 | 0.68224152 |
| 70 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.66534701 |
| 71 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.65295180 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63517066 |
| 73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63028695 |
| 74 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62885692 |
| 75 | Adherens junction_Homo sapiens_hsa04520 | 0.62649328 |
| 76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62192502 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61490069 |
| 78 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.60961171 |
| 79 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.60341427 |
| 80 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.58065562 |
| 81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56968779 |
| 82 | Colorectal cancer_Homo sapiens_hsa05210 | 0.56553355 |
| 83 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56059885 |
| 84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54020506 |
| 85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53736098 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53506279 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53442151 |
| 88 | Focal adhesion_Homo sapiens_hsa04510 | 0.52403222 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50109438 |
| 90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48533503 |
| 91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46106164 |
| 92 | Pathways in cancer_Homo sapiens_hsa05200 | 0.43116686 |
| 93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.42935543 |
| 94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41777834 |
| 95 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41580480 |
| 96 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.40000405 |
| 97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.39050124 |
| 98 | Endocytosis_Homo sapiens_hsa04144 | 0.37530556 |
| 99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37421113 |
| 100 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37237487 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36971801 |
| 102 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.36792868 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.36491125 |
| 104 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.36189814 |
| 105 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.35937540 |
| 106 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.35384297 |
| 107 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34303239 |
| 108 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.34084113 |
| 109 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.33284050 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.32705394 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.28526027 |
| 112 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.28243068 |
| 113 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.27631192 |
| 114 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.25848842 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.25207559 |
| 116 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.25091719 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.24662761 |
| 118 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.23959497 |

